First AD

Second AD

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Precision Medicine in Advanced Non-Small Cell Lung Cancer

Peer Exchange

Best Practices in Molecular Profiling in NSCLC

Osimertinib As Frontline Therapy in EGFR-Positive NSCLC

Osimertinib in EGFR-Positive NSCLC With Brain Metastases

Sequencing With Osimertinib in EGFR-Positive NSCLC

Resistance Mechanisms in EGFR-Positive NSCLC

Managing Resistance to EGFR TKIs in NSCLC

Afatinib Therapy for Uncommon EGFR Alterations in NSCLC

EGFR TKIs as Adjuvant Therapy in NSCLC

Emerging Therapies in EGFR-Positive NSCLC

Alectinib in ALK-Mutated NSCLC

Treating ALK-Mutated NSCLC With Disease Progression

Managing Resistance to ALK Inhibitors in NSCLC

Treatment Considerations in ALK/ROS-1 Rearranged NSCLC

Combination Therapy in BRAF-Mutant NSCLC

Treating Rare Actionable Mutations in NSCLC

Significance of Next-Generation Sequencing in NSCLC

Rationale for Liquid Biopsies in NSCLC